Scarica l'app Stockscreener
5.60
0.18%
-0.01
Dopo l'orario di chiusura:
5.60
Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
When the Price of (LFCR) Talks, People Listen - Stock Traders Daily
Lifecore Biomedical (NASDAQ:LFCR) Trading 3.8% HigherHere's What Happened - MarketBeat
NASDAQ: LFCR Lawsuit NOTICE: Investors Who Lost Money With Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) Should Contact the Shareholders Foundation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - Markets Insider
Lifecore Biomedical (NASDAQ:LFCR) Stock Price Up 3.8% – Should You Buy? - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
(LFCR) Technical Data - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation - Markets Insider
Sept. 27th Deadline Alert: Investors Who Lost More Than $100,000 With Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Should Contact the Shareholders Foundation - ACCESS Newswire
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - Markets Insider
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - Markets Insider
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - Markets Insider
(LFCR) Investment Analysis - Stock Traders Daily
Lifecore Biomedical’s Earnings Call: Growth Amid Challenges - TipRanks
This Lifecore Biomedical Insider Increased Their Holding In The Last Year - Yahoo Finance
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Barclays PLC - Defense World
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Short Interest Update - MarketBeat
Lifecore Biomedical Announces Special Stockholder Meeting - The Manila Times
Lifecore Biomedical Calls Special Meeting to Vote on Preferred Stock Conversion Cap Removal - StockTitan
Jane Street Group LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
LFCR FY2025 EPS Forecast Boosted by Barrington Research - Defense World
LFCR FY2025 EPS Forecast Lifted by Barrington Research - MarketBeat
Paul Josephs Bought 3.1% More Shares In Lifecore Biomedical - Simply Wall St
Lifecore Biomedical, Inc. (NASDAQ:LFCR) CEO Paul Josephs Acquires 17,000 Shares - MarketBeat
Geode Capital Management LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Barclays PLC Has $147,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Lifecore Biomedical to sell multi-purpose 10-head isolator filler - MSN
Lifecore Biomedical Sells Excess Capital Equipment for $17M - Contract Pharma
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million - The Manila Times
Lifecore Biomedical Secures $17M Equipment Sale, Doubles Production Capacity with New Filler - StockTitan
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024 - MSN
Lifecore Biomedical to Present at 2025 J.P. Morgan Healthcare Conference in San Francisco - StockTitan
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Lifecore Biomedical, Inc. and Encourages Investors to Contact the Firm - AccessWire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript - MSN
Lifecore Biomedical’s (LFCR) “Equal Weight” Rating Reaffirmed at Stephens - Defense World
0.92%
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):